Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
YANCHANG PETRO
00346
CN Stock MarketDetailed Quotes
Wuhan Easy Diagnosis Biomedicine (002932)
- 17.04
- +0.02+0.12%
Trading Apr 17 10:07 CST
3.96BMarket Cap549.68P/E (TTM)
17.15High16.85Low8.93KlotVolume17.02Open17.02Prev Close15.22MTurnover0.57%Turnover Ratio53.25P/E (Static)232.52MShares23.2852wk High0.71P/B2.66BFloat Cap15.2852wk Low18.72Limit Up156.09MShs Float58.49Historical High15.32Limit Down1.76%Range %0.20Historical Low1.20Dividend TTM17.04Avg Price3.75KlotAsk7.04%Div Yield TTM100Lot Size4.50KlotBid
Wuhan Easy Diagnosis Biomedicine (002932) Income Statement
All
YOY
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 0.53%226.81M | -9.71%139.29M | 14.76%69.96M | -53.30%350.06M | -63.95%225.62M | -71.30%154.27M | -83.63%60.96M | -92.88%749.54M | -91.62%625.93M | -89.77%537.56M |
| Operating revenue | 0.53%226.81M | -9.71%139.29M | 14.76%69.96M | -53.30%350.06M | -63.95%225.62M | -71.30%154.27M | -83.63%60.96M | -92.88%749.54M | -91.62%625.93M | -89.77%537.56M |
| Other operating revenue | ---- | --421.34K | ---- | 15.86%52.68K | ---- | --0 | ---- | --45.47K | ---- | --0 |
| Total operating cost | 4.18%333.28M | -2.87%206.08M | 9.60%114.19M | -39.94%432.52M | -42.99%319.89M | -53.20%212.17M | -65.90%104.19M | -83.99%720.15M | -79.34%561.15M | -75.47%453.35M |
| Operating cost | 41.16%153.52M | 19.85%82.43M | 60.69%58.51M | -52.90%161.41M | -66.40%108.76M | -75.43%68.78M | -82.51%36.41M | -90.18%342.7M | -85.91%323.72M | -82.69%279.97M |
| Operating tax surcharges | 188.29%2.86M | 179.06%1.96M | 202.71%925.08K | -33.00%1.51M | -62.41%992.15K | -69.33%703.19K | -82.98%305.6K | -96.24%2.25M | -93.71%2.64M | -92.69%2.29M |
| Operating expense | -13.38%68.14M | -11.82%48.44M | -22.67%18.62M | -26.41%85.32M | -31.89%78.66M | -33.09%54.93M | -47.61%24.08M | -74.28%115.95M | -38.92%115.48M | -34.73%82.1M |
| Administration expense | -19.71%41.73M | -26.10%27.7M | -29.47%13.29M | -25.17%84.29M | -33.64%51.98M | -28.34%37.49M | -33.02%18.84M | -20.67%112.64M | 26.87%78.33M | 37.23%52.31M |
| Financial expense | 75.58%-1.65M | 74.23%-1.28M | 35.29%-1.7M | -283.97%-9.56M | 89.73%-6.74M | 85.95%-4.95M | 77.71%-2.63M | 114.87%5.19M | -115.39%-65.66M | -63.32%-35.26M |
| -Interest expense (Financial expense) | -73.95%122.68K | --59.15K | -94.85%29.25K | -87.76%1.28M | -59.94%470.92K | ---- | --567.94K | 206.73%10.5M | -38.55%1.18M | 84.58%2.46M |
| -Interest Income (Financial expense) | 56.51%-3.57M | 42.48%-2.98M | 18.06%-2.19M | -137.14%-10.4M | 88.48%-8.21M | 85.77%-5.18M | ---2.68M | 75.26%-4.39M | -508.99%-71.2M | -351.55%-36.36M |
| Research and development | -20.37%68.67M | -15.22%46.82M | -9.68%24.55M | -22.53%109.55M | -19.12%86.24M | -23.23%55.22M | -18.09%27.18M | -63.59%141.42M | -31.34%106.63M | 26.41%71.93M |
| Credit Impairment Loss | -147.22%-12.68M | 28.38%2.44M | 307.19%14.26M | 94.99%-4.01M | -62.61%26.85M | -95.67%1.9M | -352.58%-6.88M | 78.40%-79.95M | 199.34%71.82M | 173.43%43.87M |
| Asset Impairment Loss | ---- | --0 | ---- | -1,928.62%-86.92M | ---- | --0 | ---- | 100.74%4.75M | --36.33M | ---- |
| Other net revenue | -49.41%89.32M | -40.42%76.27M | -46.13%41.8M | 6.77%123.65M | 14.23%176.56M | 48.07%128.01M | 151.33%77.6M | 112.15%115.8M | 413.32%154.57M | 288.91%86.45M |
| Fair value change income | -280.45%-1.15M | -280.45%-1.15M | ---- | -62.16%1.74M | --637.06K | --637.06K | ---- | 66.25%4.59M | --0 | ---- |
| Invest income | -4.65%74.81M | -8.98%49.94M | 0.55%27.01M | 10.91%133.7M | 164.45%78.46M | 87.40%54.86M | 20.82%26.86M | 243.25%120.55M | 87.02%29.67M | 292.16%29.28M |
| -Including: Investment income associates | ---- | 189.56%808.08K | ---- | 81.42%-1.25M | 61.82%-902.26K | 61.82%-902.26K | ---- | -31.27%-6.73M | ---2.36M | -637.28%-2.36M |
| Asset deal income | 645.39%613.3K | -76.19%74K | ---- | 482.18%1.79M | 119.91%82.28K | 215.49%310.79K | ---36.01K | 3,062.38%307.82K | ---413.2K | ---269.11K |
| Other revenue | -60.68%27.73M | -64.48%24.97M | -99.06%539.92K | 17.98%77.34M | 310.97%70.53M | 417.83%70.3M | 873.67%57.66M | 156.47%65.56M | 141.64%17.16M | 108.53%13.57M |
| Operating profit | -120.84%-17.15M | -86.48%9.48M | -107.06%-2.43M | -71.63%41.19M | -62.49%82.28M | -58.92%70.11M | -64.85%34.37M | -97.14%145.19M | -95.34%219.35M | -94.92%170.66M |
| Add:Non operating Income | 4,849.52%16.76M | -29.22%125.33K | -78.46%26.98K | 335.41%3.82M | -24.28%338.53K | -19.77%177.07K | 136.34%125.22K | 419.64%877.52K | 157.28%447.09K | 35.78%220.71K |
| Less:Non operating expense | 7.52%4.89M | 9.07%2.8M | 317.82%1.57M | 103.67%12.59M | -18.88%4.54M | -38.97%2.57M | -80.57%375.62K | 71.52%6.18M | 134.63%5.6M | 113.31%4.21M |
| Total profit | -106.76%-5.28M | -89.96%6.8M | -111.63%-3.97M | -76.83%32.42M | -63.55%78.07M | -59.37%67.72M | -64.42%34.12M | -97.24%139.89M | -95.45%214.19M | -95.04%166.67M |
| Less:Income tax cost | -54.37%7.17M | -98.65%175.12K | -109.39%-564.46K | -91.72%5.85M | -50.17%15.71M | -47.53%12.94M | -58.36%6.01M | -89.84%70.67M | -95.60%31.53M | -95.28%24.67M |
| Net profit | -119.96%-12.45M | -87.90%6.63M | -112.11%-3.41M | -61.62%26.56M | -65.86%62.36M | -61.43%54.77M | -65.49%28.11M | -98.42%69.22M | -95.42%182.66M | -94.99%142M |
| Net profit from continuing operation | -119.96%-12.45M | -87.90%6.63M | -112.11%-3.41M | -61.62%26.56M | -65.86%62.36M | -61.43%54.77M | -65.49%28.11M | -98.42%69.22M | -95.42%182.66M | -94.99%142M |
| Net income from discontinuing operating | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Less:Minority Profit | -39.77%-25.96M | 43.49%-5.87M | 106.54%257.81K | -739.91%-47.95M | -149.71%-18.57M | -135.31%-10.39M | -165.68%-3.94M | -103.32%-5.71M | -74.74%37.36M | -60.64%29.43M |
| Net profit of parent company owners | -83.30%13.52M | -80.82%12.5M | -111.43%-3.66M | -0.54%74.52M | -44.30%80.94M | -42.12%65.16M | -57.52%32.05M | -98.22%74.93M | -96.21%145.3M | -95.92%112.57M |
| Earning per share | ||||||||||
| Basic earning per share | -82.40%0.0616 | -78.57%0.06 | -114.29%-0.02 | 0.00%0.33 | -44.44%0.35 | -42.86%0.28 | -71.43%0.14 | -98.21%0.33 | -96.26%0.63 | -95.94%0.49 |
| Diluted earning per share | -82.40%0.0616 | -78.57%0.06 | -114.29%-0.02 | 0.00%0.33 | -44.44%0.35 | -41.67%0.28 | -70.83%0.14 | -98.20%0.33 | -96.20%0.63 | -95.97%0.48 |
| Other composite income | 3.72M | |||||||||
| Other composite income of parent company owners | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --3.72M |
| Total composite income | -119.96%-12.45M | -87.90%6.63M | -112.11%-3.41M | -61.62%26.56M | -65.86%62.36M | -62.41%54.77M | -65.49%28.11M | -98.42%69.22M | -95.42%182.66M | -94.86%145.72M |
| Total composite income of parent company owners | -83.30%13.52M | -80.82%12.5M | -111.43%-3.66M | -0.54%74.52M | -44.30%80.94M | -43.97%65.16M | -57.52%32.05M | -98.22%74.93M | -96.21%145.3M | -95.79%116.29M |
| Total composite income of minority owners | -39.77%-25.96M | 43.49%-5.87M | 106.54%257.81K | -739.91%-47.95M | -149.71%-18.57M | -135.31%-10.39M | -165.68%-3.94M | -103.32%-5.71M | -74.74%37.36M | -60.64%29.43M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! On the 16th, US President Trump stated that the next round of talks between the US and
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm